Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation by Claudio Ucciferri, Antonio Auricchio, Jacopo Vecchiet, Katia Falasca

Get full text

Cardiac toxicity associated with HCV direct antiviral agents by Claudio Ucciferri, Alessandro Occhionero, Jacopo Vecchiet, Katia Falasca

Get full text

PIDOTIMOD IN PAUCISYMPTOMATIC SARS-CoV2 INFECTED PATIENTS by Claudio Ucciferri, Barone Mirko, Jacopo Vecchiet, Katia Falasca

Get full text

USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS by Paola Mancino, Katia Falasca, Claudio Ucciferri, Eligio Pizzigallo, Jacopo Vecchiet

Get full text

USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS by Claudio Ucciferri, Katia Falasca, Paola Mancino, Eligio Pizzigallo, Jacopo Vecchiet

Get full text

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vacc... by Lorenzo Piermatteo, Stefano D’Anna, Ada Bertoli, Maria Bellocchi, Luca Carioti, Lavinia Fabeni, Mohammad Alkhatib, Simone La Frazia, Miriam Lichtner, Claudio Mastroianni, Giuseppe De Sanctis, Massimo Marignani, Caterina Pasquazzi, Nerio Iapadre, Giustino Parruti, Giuseppina Cappiello, Jacopo Vecchiet, Vincenzo Malagnino, Sandro Grelli, Francesca Ceccherini-Silbertein, Massimo Andreoni, Loredana Sarmati, Valentina Svicher, Romina Salpini

Get full text